Status:
TERMINATED
Management of Complex Wounds Using a Constant Tension External Tissue Expander
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Wounds and Injuries
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Complex wounds that cannot be closed primarily are at great risk for complications. A new technique utilizing external tissue expansion holds promise in rapidly decreasing wound area. Facilitation of ...
Detailed Description
Upon IRB approval, 50 patients with complex soft tissue wounds, with or without an associated fracture that cannot be closed primarily will have the Dermaclose device applied and will be prospectively...
Eligibility Criteria
Inclusion
- Age 18 or greater
- Has soft tissue wound(s) that are unable to be closed primarily
Exclusion
- Age less than 18
- Has wound(s) that can be closed primarily
- Infected wound
- Unable to comply with protocol
- Prior radiation treatment to skin or soft tissues in the area of the wound
- Friable wound margins
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2015
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT01171521
Start Date
July 1 2010
End Date
September 1 2015
Last Update
February 26 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri Hospital and Clinics
Columbia, Missouri, United States, 65212